Review




Structured Review

Condalab e coli coliforms chromogenic medium
E Coli Coliforms Chromogenic Medium, supplied by Condalab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/1356+agar+base+iso+pseudomonas/10__61310_slash_mjst__v23i1__2393-78-26-32
Average 86 stars, based on 1 article reviews
e coli coliforms chromogenic medium - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

Concentration Assay:

Article Title: Bacterial behavior on coated porous titanium substrates for biomedical applications
Article Snippet: In this work, bacterial behavior on dense and porous titanium substrates is discussed.. Porous titanium was fabricated by a space holder technique (using 50 vol%, NH4HCO3 with particle sizes between 250 and 355 μm).. These substrates were coated by sulfonated PEEK (termed SPEEK).

Filtration:

Article Title: Bacterial behavior on coated porous titanium substrates for biomedical applications
Article Snippet: In this work, bacterial behavior on dense and porous titanium substrates is discussed.. Porous titanium was fabricated by a space holder technique (using 50 vol%, NH4HCO3 with particle sizes between 250 and 355 μm).. These substrates were coated by sulfonated PEEK (termed SPEEK).

Incubation:

Article Title: Bacterial behavior on coated porous titanium substrates for biomedical applications
Article Snippet: In this work, bacterial behavior on dense and porous titanium substrates is discussed.. Porous titanium was fabricated by a space holder technique (using 50 vol%, NH4HCO3 with particle sizes between 250 and 355 μm).. These substrates were coated by sulfonated PEEK (termed SPEEK).



Similar Products

86
Condalab e coli coliforms chromogenic medium
E Coli Coliforms Chromogenic Medium, supplied by Condalab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/1356+agar+base+iso+pseudomonas/10__61310_slash_mjst__v23i1__2393-78-26-32
Average 86 stars, based on 1 article reviews
e coli coliforms chromogenic medium - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

99
Thermo Fisher chromogenic medium brilliancetm e coli coliform selective agar
Numbers of antibiotic-resistant ( E ) coli isolates across locations, sources, and sampling periods. Panel (A) : Percentage resistances of <t>E.</t> <t>coli</t> isolates against 24 antibiotics across three locations A, B, and C Bar chart, see legend for different antibiotics prevalence. Panel (B) : Prevalence of antibiotic resistance based on location without consideration of different sources or particular antibiotics (location A n=216, location B n=160, location C n=32), source (HU n=81, SH n=73, SI n=96, SO n=106, RU n=21, RD n=31), and sampling period (sampling period 1 n=217, sampling period n=191). Box and whiskers plots show median and quartiles in antibiotic resistance based on different characteristics. Sources HU – UTI isolates, RD – downstream river water, RU – upstream river water, SH – hospital wastewater, SI -WWTP inflow, SO – WWTP outflow. Number of isolates in Location A: UTI (n=42), SH (n=30), SI (n=55), SO (n=56), RU (n=12), RD (n=21). Location B: UTI (n=30), SH (n=20), SI (n=41), SO (n=50), RU (n=9), RD (n=10). Location C: UTI (n=9), SH (n=23). Antibiotic AMK, amikacin; AMP, ampicillin; AMS, ampicillin + sulbactam; AZT, aztreonam; CAZ, ceftazidime; CEP, cefepime; CFZ, cefazolin; CIP, ciprofloxacin; CMP, chloramphenicol; COL, colistin; CPS, cefoperazone + sulbactam; CPZ, cefoperazone; CTX, cefotaxime; CXM, cefuroxime; ERT, ertapenem; GEN, gentamicin; MER, meropenem; NET, netilmicin; PIP, piperacillin; PIT, piperacillin + tazobactam; T/S, co-trimoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramycin.
Chromogenic Medium Brilliancetm E Coli Coliform Selective Agar, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/AGAR/pmc10225658-34-37-45
Average 99 stars, based on 1 article reviews
chromogenic medium brilliancetm e coli coliform selective agar - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
Neogen harlequin e. coli or coliform chromogenic medium
Numbers of antibiotic-resistant ( E ) coli isolates across locations, sources, and sampling periods. Panel (A) : Percentage resistances of <t>E.</t> <t>coli</t> isolates against 24 antibiotics across three locations A, B, and C Bar chart, see legend for different antibiotics prevalence. Panel (B) : Prevalence of antibiotic resistance based on location without consideration of different sources or particular antibiotics (location A n=216, location B n=160, location C n=32), source (HU n=81, SH n=73, SI n=96, SO n=106, RU n=21, RD n=31), and sampling period (sampling period 1 n=217, sampling period n=191). Box and whiskers plots show median and quartiles in antibiotic resistance based on different characteristics. Sources HU – UTI isolates, RD – downstream river water, RU – upstream river water, SH – hospital wastewater, SI -WWTP inflow, SO – WWTP outflow. Number of isolates in Location A: UTI (n=42), SH (n=30), SI (n=55), SO (n=56), RU (n=12), RD (n=21). Location B: UTI (n=30), SH (n=20), SI (n=41), SO (n=50), RU (n=9), RD (n=10). Location C: UTI (n=9), SH (n=23). Antibiotic AMK, amikacin; AMP, ampicillin; AMS, ampicillin + sulbactam; AZT, aztreonam; CAZ, ceftazidime; CEP, cefepime; CFZ, cefazolin; CIP, ciprofloxacin; CMP, chloramphenicol; COL, colistin; CPS, cefoperazone + sulbactam; CPZ, cefoperazone; CTX, cefotaxime; CXM, cefuroxime; ERT, ertapenem; GEN, gentamicin; MER, meropenem; NET, netilmicin; PIP, piperacillin; PIT, piperacillin + tazobactam; T/S, co-trimoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramycin.
Harlequin E. Coli Or Coliform Chromogenic Medium, supplied by Neogen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/harlequin+mrsa+chromogenic+agar/pmc07409191-104-106-109
Average 90 stars, based on 1 article reviews
harlequin e. coli or coliform chromogenic medium - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Condalab e. coli-coliforms chromogenic medium
Numbers of antibiotic-resistant ( E ) coli isolates across locations, sources, and sampling periods. Panel (A) : Percentage resistances of <t>E.</t> <t>coli</t> isolates against 24 antibiotics across three locations A, B, and C Bar chart, see legend for different antibiotics prevalence. Panel (B) : Prevalence of antibiotic resistance based on location without consideration of different sources or particular antibiotics (location A n=216, location B n=160, location C n=32), source (HU n=81, SH n=73, SI n=96, SO n=106, RU n=21, RD n=31), and sampling period (sampling period 1 n=217, sampling period n=191). Box and whiskers plots show median and quartiles in antibiotic resistance based on different characteristics. Sources HU – UTI isolates, RD – downstream river water, RU – upstream river water, SH – hospital wastewater, SI -WWTP inflow, SO – WWTP outflow. Number of isolates in Location A: UTI (n=42), SH (n=30), SI (n=55), SO (n=56), RU (n=12), RD (n=21). Location B: UTI (n=30), SH (n=20), SI (n=41), SO (n=50), RU (n=9), RD (n=10). Location C: UTI (n=9), SH (n=23). Antibiotic AMK, amikacin; AMP, ampicillin; AMS, ampicillin + sulbactam; AZT, aztreonam; CAZ, ceftazidime; CEP, cefepime; CFZ, cefazolin; CIP, ciprofloxacin; CMP, chloramphenicol; COL, colistin; CPS, cefoperazone + sulbactam; CPZ, cefoperazone; CTX, cefotaxime; CXM, cefuroxime; ERT, ertapenem; GEN, gentamicin; MER, meropenem; NET, netilmicin; PIP, piperacillin; PIT, piperacillin + tazobactam; T/S, co-trimoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramycin.
E. Coli Coliforms Chromogenic Medium, supplied by Condalab, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/e++coli+coliforms+chromogenic+medium/10__3390_slash_met9101039-67-16-21
Average 90 stars, based on 1 article reviews
e. coli-coliforms chromogenic medium - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Nissui Pharmaceutical compact dry plate with chromogenic nutrient medium for the detection of coliforms and e. coli
Numbers of antibiotic-resistant ( E ) coli isolates across locations, sources, and sampling periods. Panel (A) : Percentage resistances of <t>E.</t> <t>coli</t> isolates against 24 antibiotics across three locations A, B, and C Bar chart, see legend for different antibiotics prevalence. Panel (B) : Prevalence of antibiotic resistance based on location without consideration of different sources or particular antibiotics (location A n=216, location B n=160, location C n=32), source (HU n=81, SH n=73, SI n=96, SO n=106, RU n=21, RD n=31), and sampling period (sampling period 1 n=217, sampling period n=191). Box and whiskers plots show median and quartiles in antibiotic resistance based on different characteristics. Sources HU – UTI isolates, RD – downstream river water, RU – upstream river water, SH – hospital wastewater, SI -WWTP inflow, SO – WWTP outflow. Number of isolates in Location A: UTI (n=42), SH (n=30), SI (n=55), SO (n=56), RU (n=12), RD (n=21). Location B: UTI (n=30), SH (n=20), SI (n=41), SO (n=50), RU (n=9), RD (n=10). Location C: UTI (n=9), SH (n=23). Antibiotic AMK, amikacin; AMP, ampicillin; AMS, ampicillin + sulbactam; AZT, aztreonam; CAZ, ceftazidime; CEP, cefepime; CFZ, cefazolin; CIP, ciprofloxacin; CMP, chloramphenicol; COL, colistin; CPS, cefoperazone + sulbactam; CPZ, cefoperazone; CTX, cefotaxime; CXM, cefuroxime; ERT, ertapenem; GEN, gentamicin; MER, meropenem; NET, netilmicin; PIP, piperacillin; PIT, piperacillin + tazobactam; T/S, co-trimoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramycin.
Compact Dry Plate With Chromogenic Nutrient Medium For The Detection Of Coliforms And E. Coli, supplied by Nissui Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/compact+dry+plate+with+chromogenic+nutrient+medium+for+the+detection+of+coliforms+and+e++coli/pmc06121632__ijerph___15___01616___s001-24-73-77
Average 90 stars, based on 1 article reviews
compact dry plate with chromogenic nutrient medium for the detection of coliforms and e. coli - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Fisher Scientific chromogenic brilliant e. coli and coliform medium
Numbers of antibiotic-resistant ( E ) coli isolates across locations, sources, and sampling periods. Panel (A) : Percentage resistances of <t>E.</t> <t>coli</t> isolates against 24 antibiotics across three locations A, B, and C Bar chart, see legend for different antibiotics prevalence. Panel (B) : Prevalence of antibiotic resistance based on location without consideration of different sources or particular antibiotics (location A n=216, location B n=160, location C n=32), source (HU n=81, SH n=73, SI n=96, SO n=106, RU n=21, RD n=31), and sampling period (sampling period 1 n=217, sampling period n=191). Box and whiskers plots show median and quartiles in antibiotic resistance based on different characteristics. Sources HU – UTI isolates, RD – downstream river water, RU – upstream river water, SH – hospital wastewater, SI -WWTP inflow, SO – WWTP outflow. Number of isolates in Location A: UTI (n=42), SH (n=30), SI (n=55), SO (n=56), RU (n=12), RD (n=21). Location B: UTI (n=30), SH (n=20), SI (n=41), SO (n=50), RU (n=9), RD (n=10). Location C: UTI (n=9), SH (n=23). Antibiotic AMK, amikacin; AMP, ampicillin; AMS, ampicillin + sulbactam; AZT, aztreonam; CAZ, ceftazidime; CEP, cefepime; CFZ, cefazolin; CIP, ciprofloxacin; CMP, chloramphenicol; COL, colistin; CPS, cefoperazone + sulbactam; CPZ, cefoperazone; CTX, cefotaxime; CXM, cefuroxime; ERT, ertapenem; GEN, gentamicin; MER, meropenem; NET, netilmicin; PIP, piperacillin; PIT, piperacillin + tazobactam; T/S, co-trimoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramycin.
Chromogenic Brilliant E. Coli And Coliform Medium, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/brilliance+e++coli++coliform+selective+agar/pmc05515937-120-14-16
Average 90 stars, based on 1 article reviews
chromogenic brilliant e. coli and coliform medium - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Nissui Pharmaceutical e. coli -coliforms chromogenic mediums
Antibiotic resistance rates of the <t>E.</t> <t>coli</t> isolated from drinking water sources (the Qiantang River and the Dongtiao Stream). AN, amikacin; GM: gentamicin; IPM, imipenem; MEM, meropenem; CZ, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PIP, piperacillin; AMC, amoxicillin/clavulanate; SAM, ampicillin/sulbactam; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; TE, tetracycline.
E. Coli Coliforms Chromogenic Mediums, supplied by Nissui Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/e++coli++coliforms+chromogenic+mediums/pmc05472731-104-5-10
Average 90 stars, based on 1 article reviews
e. coli -coliforms chromogenic mediums - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Thermo Fisher chromogenic e. coli/coliform medium
Antibiotic resistance rates of the <t>E.</t> <t>coli</t> isolated from drinking water sources (the Qiantang River and the Dongtiao Stream). AN, amikacin; GM: gentamicin; IPM, imipenem; MEM, meropenem; CZ, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PIP, piperacillin; AMC, amoxicillin/clavulanate; SAM, ampicillin/sulbactam; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; TE, tetracycline.
Chromogenic E. Coli/Coliform Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e%2E+coli-coliforms+chromogenic+medium/10__1556_slash_066__2017__46__1__5-54-26-30
Average 90 stars, based on 1 article reviews
chromogenic e. coli/coliform medium - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Numbers of antibiotic-resistant ( E ) coli isolates across locations, sources, and sampling periods. Panel (A) : Percentage resistances of E. coli isolates against 24 antibiotics across three locations A, B, and C Bar chart, see legend for different antibiotics prevalence. Panel (B) : Prevalence of antibiotic resistance based on location without consideration of different sources or particular antibiotics (location A n=216, location B n=160, location C n=32), source (HU n=81, SH n=73, SI n=96, SO n=106, RU n=21, RD n=31), and sampling period (sampling period 1 n=217, sampling period n=191). Box and whiskers plots show median and quartiles in antibiotic resistance based on different characteristics. Sources HU – UTI isolates, RD – downstream river water, RU – upstream river water, SH – hospital wastewater, SI -WWTP inflow, SO – WWTP outflow. Number of isolates in Location A: UTI (n=42), SH (n=30), SI (n=55), SO (n=56), RU (n=12), RD (n=21). Location B: UTI (n=30), SH (n=20), SI (n=41), SO (n=50), RU (n=9), RD (n=10). Location C: UTI (n=9), SH (n=23). Antibiotic AMK, amikacin; AMP, ampicillin; AMS, ampicillin + sulbactam; AZT, aztreonam; CAZ, ceftazidime; CEP, cefepime; CFZ, cefazolin; CIP, ciprofloxacin; CMP, chloramphenicol; COL, colistin; CPS, cefoperazone + sulbactam; CPZ, cefoperazone; CTX, cefotaxime; CXM, cefuroxime; ERT, ertapenem; GEN, gentamicin; MER, meropenem; NET, netilmicin; PIP, piperacillin; PIT, piperacillin + tazobactam; T/S, co-trimoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramycin.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: Hospital and community wastewater as a source of multidrug-resistant ESBL-producing Escherichia coli

doi: 10.3389/fcimb.2023.1184081

Figure Lengend Snippet: Numbers of antibiotic-resistant ( E ) coli isolates across locations, sources, and sampling periods. Panel (A) : Percentage resistances of E. coli isolates against 24 antibiotics across three locations A, B, and C Bar chart, see legend for different antibiotics prevalence. Panel (B) : Prevalence of antibiotic resistance based on location without consideration of different sources or particular antibiotics (location A n=216, location B n=160, location C n=32), source (HU n=81, SH n=73, SI n=96, SO n=106, RU n=21, RD n=31), and sampling period (sampling period 1 n=217, sampling period n=191). Box and whiskers plots show median and quartiles in antibiotic resistance based on different characteristics. Sources HU – UTI isolates, RD – downstream river water, RU – upstream river water, SH – hospital wastewater, SI -WWTP inflow, SO – WWTP outflow. Number of isolates in Location A: UTI (n=42), SH (n=30), SI (n=55), SO (n=56), RU (n=12), RD (n=21). Location B: UTI (n=30), SH (n=20), SI (n=41), SO (n=50), RU (n=9), RD (n=10). Location C: UTI (n=9), SH (n=23). Antibiotic AMK, amikacin; AMP, ampicillin; AMS, ampicillin + sulbactam; AZT, aztreonam; CAZ, ceftazidime; CEP, cefepime; CFZ, cefazolin; CIP, ciprofloxacin; CMP, chloramphenicol; COL, colistin; CPS, cefoperazone + sulbactam; CPZ, cefoperazone; CTX, cefotaxime; CXM, cefuroxime; ERT, ertapenem; GEN, gentamicin; MER, meropenem; NET, netilmicin; PIP, piperacillin; PIT, piperacillin + tazobactam; T/S, co-trimoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramycin.

Article Snippet: Water samples were first serially ten-fold diluted or concentrated using filtering (0.22 μm; Sigma-Aldrich, US) before plating (depending on presumed amount of viable bacterial colonies in the various types of samples) and then cultivated in triplicate on chromogenic medium BrillianceTM E. coli /coliform Selective Agar (Oxoid, UK) at 37 °C overnight.

Techniques: Sampling

The percentage of E. coli isolates (n=408) with beta-lactamase encoding genes based on the source. Bar chart presents the prevalence of ESBL, AmpC, and carbapenemase-encoding genes. Source HU, UTI isolates; RD, downstream river water; RU, upstream river water; SH, hospital wastewater; SI, WWTP inflow; SO, WWTP outflow.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: Hospital and community wastewater as a source of multidrug-resistant ESBL-producing Escherichia coli

doi: 10.3389/fcimb.2023.1184081

Figure Lengend Snippet: The percentage of E. coli isolates (n=408) with beta-lactamase encoding genes based on the source. Bar chart presents the prevalence of ESBL, AmpC, and carbapenemase-encoding genes. Source HU, UTI isolates; RD, downstream river water; RU, upstream river water; SH, hospital wastewater; SI, WWTP inflow; SO, WWTP outflow.

Article Snippet: Water samples were first serially ten-fold diluted or concentrated using filtering (0.22 μm; Sigma-Aldrich, US) before plating (depending on presumed amount of viable bacterial colonies in the various types of samples) and then cultivated in triplicate on chromogenic medium BrillianceTM E. coli /coliform Selective Agar (Oxoid, UK) at 37 °C overnight.

Techniques:

Phylogenetic tree of E. coli isolates based on SNP analysis. See legend for phylogenetic group, location, source, variant of CTX-M beta-lactamase (Others covers: bla TEM-106 , bla CTX-M-8 , bla CTX-M-65 , bla CTX-M-32 , bla CTX-M-134 ), presence of genes encoding resistance to carbapenems, STs, four most prevalent STs of F type plasmids (FAB formulas), and presence of ColV plasmids (purple stars). Colored STs were repeatedly mentioned in the manuscript. Read coding as: sampling period (1, 2), HU, UTI isolates; RD, downstream river water; RU, upstream river water; SH, hospital wastewater; SI, WWTP inflow; SO - WWTP outflow, location (A–C), number of isolates, cultivation on plate with antibiotics (c – cefotaxime/m – meropenem), variant of isolate (optionally, if from one plate two morphologically different colonies were taken).

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: Hospital and community wastewater as a source of multidrug-resistant ESBL-producing Escherichia coli

doi: 10.3389/fcimb.2023.1184081

Figure Lengend Snippet: Phylogenetic tree of E. coli isolates based on SNP analysis. See legend for phylogenetic group, location, source, variant of CTX-M beta-lactamase (Others covers: bla TEM-106 , bla CTX-M-8 , bla CTX-M-65 , bla CTX-M-32 , bla CTX-M-134 ), presence of genes encoding resistance to carbapenems, STs, four most prevalent STs of F type plasmids (FAB formulas), and presence of ColV plasmids (purple stars). Colored STs were repeatedly mentioned in the manuscript. Read coding as: sampling period (1, 2), HU, UTI isolates; RD, downstream river water; RU, upstream river water; SH, hospital wastewater; SI, WWTP inflow; SO - WWTP outflow, location (A–C), number of isolates, cultivation on plate with antibiotics (c – cefotaxime/m – meropenem), variant of isolate (optionally, if from one plate two morphologically different colonies were taken).

Article Snippet: Water samples were first serially ten-fold diluted or concentrated using filtering (0.22 μm; Sigma-Aldrich, US) before plating (depending on presumed amount of viable bacterial colonies in the various types of samples) and then cultivated in triplicate on chromogenic medium BrillianceTM E. coli /coliform Selective Agar (Oxoid, UK) at 37 °C overnight.

Techniques: Variant Assay, Sampling

Antibiotic resistance rates of the E. coli isolated from drinking water sources (the Qiantang River and the Dongtiao Stream). AN, amikacin; GM: gentamicin; IPM, imipenem; MEM, meropenem; CZ, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PIP, piperacillin; AMC, amoxicillin/clavulanate; SAM, ampicillin/sulbactam; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; TE, tetracycline.

Journal: Frontiers in Microbiology

Article Title: Prevalence of Antibiotic-Resistant Escherichia coli in Drinking Water Sources in Hangzhou City

doi: 10.3389/fmicb.2017.01133

Figure Lengend Snippet: Antibiotic resistance rates of the E. coli isolated from drinking water sources (the Qiantang River and the Dongtiao Stream). AN, amikacin; GM: gentamicin; IPM, imipenem; MEM, meropenem; CZ, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PIP, piperacillin; AMC, amoxicillin/clavulanate; SAM, ampicillin/sulbactam; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; TE, tetracycline.

Article Snippet: The membranes were placed on E. coli -Coliforms Chromogenic Mediums (Nissui, Qingdao, China) and incubated at 37°C for 24 h. After incubation, blue colonies represented E. coli .

Techniques: Isolation

Antibiotic resistance rates of the E. coli isolated from the Qiantang River and the Dongtiao Stream over two seasons. AN, amikacin; GM, gentamicin; IPM, imipenem; MEM, meropenem; CZ, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PIP, piperacillin; AMC, amoxicillin/clavulanate; SAM, ampicillin/sulbactam; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; TE, tetracycline.

Journal: Frontiers in Microbiology

Article Title: Prevalence of Antibiotic-Resistant Escherichia coli in Drinking Water Sources in Hangzhou City

doi: 10.3389/fmicb.2017.01133

Figure Lengend Snippet: Antibiotic resistance rates of the E. coli isolated from the Qiantang River and the Dongtiao Stream over two seasons. AN, amikacin; GM, gentamicin; IPM, imipenem; MEM, meropenem; CZ, cefazolin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; AMP, ampicillin; PIP, piperacillin; AMC, amoxicillin/clavulanate; SAM, ampicillin/sulbactam; C, chloramphenicol; CIP, ciprofloxacin; LVX, levofloxacin; TE, tetracycline.

Article Snippet: The membranes were placed on E. coli -Coliforms Chromogenic Mediums (Nissui, Qingdao, China) and incubated at 37°C for 24 h. After incubation, blue colonies represented E. coli .

Techniques: Isolation

The distribution of antibiotic resistance rate for R1-2 and R3-6 subpopulation isolated from the Qiantang River in two seasons.

Journal: Frontiers in Microbiology

Article Title: Prevalence of Antibiotic-Resistant Escherichia coli in Drinking Water Sources in Hangzhou City

doi: 10.3389/fmicb.2017.01133

Figure Lengend Snippet: The distribution of antibiotic resistance rate for R1-2 and R3-6 subpopulation isolated from the Qiantang River in two seasons.

Article Snippet: The membranes were placed on E. coli -Coliforms Chromogenic Mediums (Nissui, Qingdao, China) and incubated at 37°C for 24 h. After incubation, blue colonies represented E. coli .

Techniques: Isolation

Spearman's rank correlation coefficients between antibiotic resistance rates of  E. coli  and water quality parameters.

Journal: Frontiers in Microbiology

Article Title: Prevalence of Antibiotic-Resistant Escherichia coli in Drinking Water Sources in Hangzhou City

doi: 10.3389/fmicb.2017.01133

Figure Lengend Snippet: Spearman's rank correlation coefficients between antibiotic resistance rates of E. coli and water quality parameters.

Article Snippet: The membranes were placed on E. coli -Coliforms Chromogenic Mediums (Nissui, Qingdao, China) and incubated at 37°C for 24 h. After incubation, blue colonies represented E. coli .

Techniques:

Association between antibiotic resistance phenotypes of  E. coli  isolates from drinking water sources.

Journal: Frontiers in Microbiology

Article Title: Prevalence of Antibiotic-Resistant Escherichia coli in Drinking Water Sources in Hangzhou City

doi: 10.3389/fmicb.2017.01133

Figure Lengend Snippet: Association between antibiotic resistance phenotypes of E. coli isolates from drinking water sources.

Article Snippet: The membranes were placed on E. coli -Coliforms Chromogenic Mediums (Nissui, Qingdao, China) and incubated at 37°C for 24 h. After incubation, blue colonies represented E. coli .

Techniques:

Antibiotic resistance of  E. coli  isolated from the Qiantang River and the Dongtiao Stream over two seasons.

Journal: Frontiers in Microbiology

Article Title: Prevalence of Antibiotic-Resistant Escherichia coli in Drinking Water Sources in Hangzhou City

doi: 10.3389/fmicb.2017.01133

Figure Lengend Snippet: Antibiotic resistance of E. coli isolated from the Qiantang River and the Dongtiao Stream over two seasons.

Article Snippet: The membranes were placed on E. coli -Coliforms Chromogenic Mediums (Nissui, Qingdao, China) and incubated at 37°C for 24 h. After incubation, blue colonies represented E. coli .

Techniques: Isolation